Author Details

Kurbacheva, Oksana M.

Issue	Section	Title	File
Vol 17, No 3 (2020)	Reviews	Non-steroidal anti-inflammatory drugs (NSAIDs) – exacerbated respiratory disease: epidemiology, pathogenesis, clinical findings and management	(Rus)
Vol 17, No 3 (2020)	Help to the practitioner	Efficacy and safety of the antileukotriene drugs: relevant data. RAACI experts conclusion	(Rus)
Vol 18, No 1 (2021)	Letters to the editor	Chronic urticaria in theory and practice. Experience of UCARE-centers for clinicians	(Rus) (Eng)
Vol 18, No 3 (2021)	Clinical practice guidelines	Vaccination of patients with allergic disease against novel coronavirus infection: position paper of the Russian Association of Allergology and Clinical Immunology	(Rus)
Vol 18, No 4 (2021)	Clinical practice guidelines	Asthma	(Rus)
Vol 19, No 1 (2022)	Clinical practice guidelines	Allergic rhinitis	(Rus)
Vol 19, No 2 (2022)	Reviews	Allergen-specific immunotherapy and real-world evidence	(Rus)
Vol 19, No 2 (2022)	Original studies	Omalizumab in the severe exacerbations of seasonal allergic rhinitis	(Rus) (Eng)
Vol 19, No 2 (2022)	Reviews	Combination therapy of allergic rhinitis: efficacy, safety and impact on quality of life	(Rus)
Vol 19, No 3 (2022)	Reviews	Molecular allergology place in allergen-specific immunotherapy	(Rus)
Vol 20, No 2 (2023)	Reviews	Searching for predictive biomarkers of allergen-specific immunotherapy efficacy based on modern concepts of its mechanisms	(Rus) (Eng)
Vol 20, No 2 (2023)	Clinical practice guidelines	Leukotriene receptor antagonists in the treatment of bronchial asthma: Consensus agreement “Bronchial Asthma and LEukoTriene receptor antagonists (BALET)”	(Rus)
Vol 21, No 1 (2024)	Short communications	Potential of the domestic biosimile omalizumab in achievement of control in patients with severe asthma: short communication	(Rus)

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies

TOP